412 related articles for article (PubMed ID: 33842321)
1. The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response.
Crake RLI; Burgess ER; Royds JA; Phillips E; Vissers MCM; Dachs GU
Front Oncol; 2021; 11():619300. PubMed ID: 33842321
[TBL] [Abstract][Full Text] [Related]
2. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the 2-oxoglutarate-dependent dioxygenases and implications for cancer.
Vissers MC; Kuiper C; Dachs GU
Biochem Soc Trans; 2014 Aug; 42(4):945-51. PubMed ID: 25109984
[TBL] [Abstract][Full Text] [Related]
4. Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases.
Kaelin WG
Cold Spring Harb Symp Quant Biol; 2011; 76():335-45. PubMed ID: 22089927
[TBL] [Abstract][Full Text] [Related]
5. Increased Ascorbate Content of Glioblastoma Is Associated With a Suppressed Hypoxic Response and Improved Patient Survival.
Burgess ER; Crake RLI; Phillips E; Morrin HR; Royds JA; Slatter TL; Wiggins GAR; Vissers MCM; Robinson BA; Dachs GU
Front Oncol; 2022; 12():829524. PubMed ID: 35419292
[TBL] [Abstract][Full Text] [Related]
6. Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence.
Vissers MCM; Das AB
Front Physiol; 2018; 9():809. PubMed ID: 30018566
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation by histone demethylases in hypoxia.
Hancock RL; Dunne K; Walport LJ; Flashman E; Kawamura A
Epigenomics; 2015 Aug; 7(5):791-811. PubMed ID: 25832587
[TBL] [Abstract][Full Text] [Related]
8. Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.
Chan MC; Ilott NE; Schödel J; Sims D; Tumber A; Lippl K; Mole DR; Pugh CW; Ratcliffe PJ; Ponting CP; Schofield CJ
J Biol Chem; 2016 Sep; 291(39):20661-73. PubMed ID: 27502280
[TBL] [Abstract][Full Text] [Related]
9. Ascorbate content of clinical glioma tissues is related to tumour grade and to global levels of 5-hydroxymethyl cytosine.
Crake RLI; Burgess ER; Wiggins GAR; Magon NJ; Das AB; Vissers MCM; Morrin HR; Royds JA; Slatter TL; Robinson BA; Phillips E; Dachs GU
Sci Rep; 2022 Sep; 12(1):14845. PubMed ID: 36050369
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Reprogramming for Targeting
Park JW; Turcan Ş
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31652645
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-driven epigenetic regulation in cancer progression: A focus on histone methylation and its modifying enzymes.
Kim I; Park JW
Cancer Lett; 2020 Oct; 489():41-49. PubMed ID: 32522693
[TBL] [Abstract][Full Text] [Related]
12. Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression.
Kuiper C; Vissers MC
Front Oncol; 2014; 4():359. PubMed ID: 25540771
[TBL] [Abstract][Full Text] [Related]
13. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
14. Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion.
Xu Y; Zhang L; Wei Y; Zhang X; Xu R; Han M; Huang B; Chen A; Li W; Zhang Q; Li G; Wang J; Zhao P; Li X
Oncotarget; 2017 Apr; 8(14):23401-23413. PubMed ID: 28423580
[TBL] [Abstract][Full Text] [Related]
15. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
Flashman E; Davies SL; Yeoh KK; Schofield CJ
Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
[TBL] [Abstract][Full Text] [Related]
16. Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate.
Chakraborty AA; Laukka T; Myllykoski M; Ringel AE; Booker MA; Tolstorukov MY; Meng YJ; Meier SR; Jennings RB; Creech AL; Herbert ZT; McBrayer SK; Olenchock BA; Jaffe JD; Haigis MC; Beroukhim R; Signoretti S; Koivunen P; Kaelin WG
Science; 2019 Mar; 363(6432):1217-1222. PubMed ID: 30872525
[TBL] [Abstract][Full Text] [Related]
17. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases.
Bruegge K; Jelkmann W; Metzen E
Curr Med Chem; 2007; 14(17):1853-62. PubMed ID: 17627521
[TBL] [Abstract][Full Text] [Related]
18. Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.
Madala HR; Punganuru SR; Arutla V; Misra S; Thomas TJ; Srivenugopal KS
Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29439493
[TBL] [Abstract][Full Text] [Related]
19. Oxygen-sensing under the influence of nitric oxide.
Berchner-Pfannschmidt U; Tug S; Kirsch M; Fandrey J
Cell Signal; 2010 Mar; 22(3):349-56. PubMed ID: 19861159
[TBL] [Abstract][Full Text] [Related]
20. Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.
Agnihotri S; Aldape KD; Zadeh G
Neurosurg Focus; 2014 Dec; 37(6):E13. PubMed ID: 25434382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
